Vectura News Discover more about our company, science, innovation and people with the latest headlines from Vectura.
Vectura highlights update made by Hikma on launch of generic Advair Diskus® Published21/04/2021 Read more
“Strategies for rapid progression of inhaled products” at Formulation & Delivery Europe Congress: Online Published15/04/2021 Read more
Vectura Expands Dry Powder Inhaler Development and Manufacturing Capabilities at its Facility in Chippenham, U.K. Published05/03/2021 Read more
Vectura Group appoints Jeanne Hecht and Jeanne Thoma to its Board of Directors Published30/12/2020 Read more
Vectura earns $11m milestone as Hikma receives US FDA approval for generic Advair Diskus® Published17/12/2020 Read more
Vectura Expands Capabilities to Handle and Develop Highly Potent Inhaled Drugs at its Facility in Chippenham, U.K. Published14/12/2020 Read more
Vectura signs agreement with Kinaset Therapeutics Inc. to support the development of VR588 to treat asthma Published30/11/2020 Read more
